Search results
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
Zacks via Yahoo Finance· 21 hours agoThe late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with...
... Meeting on Clinical Data of First-in-Class anti-CLDN18.2/CD3 Bispecific Antibody (IBI389) for...
KOIN News 6 Portland· 4 days ago...01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...
See the latest campaign finance reports; burning Pride flag in some situations, Colorado AG warns;...
Colorado Springs Gazette· 1 day agoAs of May 29, the hottest race is the Democratic Senate District 19 primary contest, where...
A culture method with berbamine, a plant alkaloid, enhances CAR-T cell efficacy through modulating...
Nature· 3 days agoWhen used in CAR-T cell processing, the plant alkaloid berbamine prolongs the survival of leukemic animals by boosting CAR-T cell viability, memory phenotype, and persistence by modulating cellular metabolism, including mitochondrial respiration.
AbbVie treats first subject in Phase III multiple myeloma drug trial
Clinical Trials Arena via Yahoo Finance· 1 day agoABBV-383 is a bispecific antibody T-cell engager that binds to both BCMA and CD3, designed to target...
Six GOP candidates vie for CD3 nomination
The Daily Sentinel· 5 days agoWhile all six have their own conservative credentials, not all have been viewed equally, including when it comes to financial support. Grand Junction...
Lilly details MASH data for tirzepatide; Cytokinetics comments on past sale talks
BioPharma Dive via Yahoo Finance· 2 days agoA study abstract shed more light on tirzepatide’s potential in MASH. Elsewhere, Cytokinetics CEO...
Nevadans react to Biden’s executive order on the border
KLAS articles via Yahoo News· 3 days agoReaction in Nevada on Tuesday to President Joe Biden's executive order on the U.S.-Mexico border...
Hanks' new residence is in GJ, but his mailing address isn't
The Daily Sentinel· 2 days agoState records show that Hanks changed his residence to Grand Junction in February, and voted in the...
TECVAYLI® (teclistamab-cqyv) shows sustained deep and durable responses in patients with relapsed or...
Forrest City Times-Herald· 4 days ago"With the longest follow-up of any bispecific antibody, teclistamab demonstrates continued deep and durable responses observed in patients with relapsed or refractory multiple myeloma who have ...